Search

Find exactly what you’re looking for.
Search

Service
Location
Showing 61-78 of 78 results
On February 1, 2023, the parties completed briefing on the Consumer Financial Protection Bureau’s (“CFPB”) petition for writ of certiorari to the U.S. Supreme Court in the case of Consumer Financial Services Association of America, Limited, v. Consumer Financial Protection Bureau (“ CFSA”). The CFPB...
​The FTC has announced the annual updates to the Hart-Scott-Rodino (“HSR”) size thresholds, fees and the daily penalty for HSR violations. The updated thresholds and fees were published in the Federal Register on January 26, 2023 and will take effect on February 27, 2023. See Federal Register...

The use of artificial intelligence (AI) to create works of art creates interesting legal challenges to the protection of intellectual property. A copyright infringement class action lawsuit has been filed against providers of AI software that is used to generate visual works of art based on...

LATEST UPDATE The FTC has voted to extend the public comment period on its proposed rule to ban employers from imposing non-competes on their workers, and will now be accepting comments on the proposed rule until April 19, 2023. Comments can still be submitted in either writing or online using the...

The use of artificial intelligence (AI) in health care, and specifically, as the utilization of software in medical devices continues to increase. Machine learning (ML) is a branch of AI in which computer systems automatically adapt, improve, and make predictions by applying algorithms to analyze...

The use of artificial intelligence (AI) to create works of art and inventions raises interesting legal challenges to the protection of intellectual property (IP). The plain language of the Copyright Act and Patent Act present obstacles to inventors and artists who may use or be AI systems. Recent...

Saul Ewing is a proud sponsor of the M&A East Conference held by the Philadelphia Chapter of the Association of Corporate Growth. M&A East attracts top strategic and financial dealmakers as well as leading middle market advisors and provides an environment for valuable networking. The conference...

On June 30th, the United States Supreme Court issued its decision in West Virginia v. EPA. The Court concluded that the EPA had exceeded its authority under the Clean Air Act by establishing emission caps in the Clean Power Plan (CPP) that would have required a shift in electrical generation from...

Saul Ewing added Katherine Barrett Wiik as a Minneapolis-based litigation and appellate partner. She earlier practiced at Best & Flanagan. (Saul Ewing)

Katherine Barrett Wiik Moves to Saul Ewing’s Minneapolis Office MINNEAPOLIS, MN—Katherine “Katie” Barrett Wiik has begun new role as a partner in Saul Ewing’s Litigation and Appellate practices.

Wake Up Call: New York AG Convenes Law Firms on Post-Roe Plans Saul Ewing hired former Robins Kaplan business litigation and appeals principal Katherine Barrett Wiik as a partner in Minneapolis.

Katherine “Katie” Barrett Wiik brings more than 15 years of experience to her new role as a partner in Saul Ewing’s Litigation and Appellate practices, including serving as lead attorney in dozens of appeals and securing favorable outcomes for clients in cases before the Sixth, Eighth, and Ninth...

Katherine “Katie” Barrett Wiik brings more than 15 years of experience to her new role as a partner in Saul Ewing’s Litigation and Appellate practices, including serving as lead attorney in dozens of appeals and securing favorable outcomes for clients in cases before the Sixth, Eighth, and Ninth...

Saul Ewing LLP, a full-service law firm with attorneys in 16 offices, today announced that 59 attorneys from the Firm received the distinguished honor of being recognized for legal excellence and client service by Chambers USA 2022. Several of the Firm’s practice areas also earned high rankings...

Washington, D.C., November 24, 2021 – Saul Ewing LLP served as counsel to Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) in the successful completion today of its previously announced $450 million acquisition of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS). The acquisition strengthens Supernus'...

For More Information
Contact us